Editorial from Graham Beastall, IFCC President

eNews-TopBanner


Method Standardization and Harmonization

Beastall -2009For several years IFCC, through its Scientific Division, has been a global leader in method standardization. Several projects have resulted in the production of reference materials, reference measurement procedures and international reference laboratories. Working with the diagnostics industry it has become possible to demonstrate traceability and commutability between these reference standards and the results obtained in service laboratories using commercial products. Method standardization has been achieved for a growing number of the most commonly performed analytes in clinical chemistry. A list of standardized methods is available from the website of the Joint Committee for Traceability in Laboratory Medicine (JCTLM), which is strongly supported by IFCC (www.bipm.org/jctlm).

This programme of method standardization will continue to be supported by IFCC. In addition, however, there is a growing realization that patient safety is being compromised by

method dependent differences for many clinically important biomarkers. This is especially true in the developing areas of microbiology and molecular diagnostics.  In many cases it is not currently possible to meet the exacting requirements of method standardization.

Consequently, a project has commenced under the leadership of the American Association of Clinical Chemistry (AACC). This project aims to reduce between method variability through harmonization rather than full standardization. A summary of the project and an explanation of the differences between standardization and harmonization have recently been published: Millar WG, Myers GL, Gantzer MLet al. Roadmap for harmonization of clinical chemistry laboratory measurement procedures.Clin Chem2011; 58: 1108-1117

IFCC supports the harmonization project and is working with AACC and other international stakeholders to introduce a co-ordinated system that enable an increased number of important biomarkers to be considered for method standardization or harmonization. This is truly a project of global importance.

Further updates will be available through future issues of IFCC News. In the mean time if you have comments or suggestions then please direct them to Graham Beastall (gbeastall@googlemail.com )